Back to Journals » Cancer Management and Research » Volume 7

Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system

Authors Zullig LL, Williams CD, Fortune-Britt AG

Received 7 October 2014

Accepted for publication 10 November 2014

Published 14 January 2015 Volume 2015:7 Pages 19—35

DOI https://doi.org/10.2147/CMAR.S75463

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Editor who approved publication: Professor Kenan Onel

Leah L Zullig,1,2 Christina D Williams,3,4 Alice G Fortune-Britt1,5

1Center for Health Services Research and Development in Primary Care, Durham Veterans Affairs Medical Center, 2Department of Medicine, Division of General Internal Medicine, Duke University Medical Center, 3Medical Service, Division of Hematology-Oncology, Durham Veterans Affairs Medical Center, 4Department of Medicine, Division of Medical Oncology, Duke University Medical Center, Durham, 5Department of Health Policy and Management, University of North Carolina, Chapel Hill, NC, USA

Abstract: Lung cancer (LC) and colorectal cancer (CRC) are the second- and third-most commonly diagnosed cancers in the Veterans Affairs (VA) health care system. While many studies have evaluated the treatment quality and outcomes of various aspects of VA LC and CRC care, there are no known reviews synthesizing this information across studies. The purpose of this literature review was to describe LC and CRC treatment (ie, surgical and nonsurgical) and outcomes (eg, mortality, psychosocial, and other) in the VA health care system as reported in the existing peer-reviewed scientific literature. We identified potential articles through a search of published literature using the PubMed electronic database. Our search strategy identified articles containing Medical Subject Headings terms and keywords addressing veterans or veterans' health and LC and/or CRC. We limited articles to those published in the previous 11 years (January 1, 2003 through December 31, 2013). A total of 230 articles were retrieved through the search. After applying the selection criteria, we included 74 studies (34 LC, 47 CRC, and seven both LC and CRC). VA provides a full array of treatments, often with better outcomes than other health care systems. More work is needed to assess patient-reported outcomes.

Keywords: colorectal neoplasms, health services research, lung neoplasms, outcome assessment (health care), review, United States Department of Veterans Affairs

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]

 

Other articles by this author:

Patient–provider communication, self-reported medication adherence, and race in a postmyocardial infarction population

Zullig LL, Shaw RJ, Shah BR, Peterson ED, Lindquist JH, Crowley MJ, Grambow SC, Bosworth HB

Patient Preference and Adherence 2015, 9:311-318

Published Date: 19 February 2015

Improving diabetes medication adherence: successful, scalable interventions

Zullig LL, Gellad WF, Moaddeb J, Crowley MJ, Shrank W, Granger BB, Granger CB, Trygstad T, Liu LZ, Bosworth HB

Patient Preference and Adherence 2015, 9:139-149

Published Date: 23 January 2015

Medication adherence: process for implementation

Mendys P, Zullig LL, Burkholder R, Granger BB, Bosworth HB

Patient Preference and Adherence 2014, 8:1025-1034

Published Date: 28 July 2014

The association of race with timeliness of care and survival among Veterans Affairs health care system patients with late-stage non-small cell lung cancer

Zullig LL, Carpenter WR, Provenzale DT, Weinberger M, Reeve BB, Williams CD, Jackson GL

Cancer Management and Research 2013, 5:157-163

Published Date: 24 July 2013

Readers of this article also read:

Emerging and future therapies for hemophilia

Carr ME, Tortella BJ

Journal of Blood Medicine 2015, 6:245-255

Published Date: 3 September 2015

Is increasing the dose of Entecavir effective in partial virological responders?

Erturk A, Adnan Akdogan R, Parlak E, Cure E, Cumhur Cure M, Ozturk C

Drug Design, Development and Therapy 2014, 8:621-625

Published Date: 29 May 2014

Green synthesis of water-soluble nontoxic polymeric nanocomposites containing silver nanoparticles

Prozorova GF, Pozdnyakov AS, Kuznetsova NP, Korzhova SA, Emel’yanov AI, Ermakova TG, Fadeeva TV, Sosedova LM

International Journal of Nanomedicine 2014, 9:1883-1889

Published Date: 16 April 2014

Methacrylic-based nanogels for the pH-sensitive delivery of 5-Fluorouracil in the colon

Ashwanikumar N, Kumar NA, Nair SA, Kumar GS

International Journal of Nanomedicine 2012, 7:5769-5779

Published Date: 15 November 2012

Cross-linked acrylic hydrogel for the controlled delivery of hydrophobic drugs in cancer therapy

Deepa G, Thulasidasan AK, Anto RJ, Pillai JJ, Kumar GS

International Journal of Nanomedicine 2012, 7:4077-4088

Published Date: 27 July 2012

Crystallization after intravitreal ganciclovir injection

Pitipol Choopong, Nattaporn Tesavibul, Nattawut Rodanant

Clinical Ophthalmology 2010, 4:709-711

Published Date: 14 July 2010